Riskpilot← Back to searchSign inGet full accessBolMed AB
ABActiveOrg 5568395106Vasavägen 47General medical practice activities · NACE 8621Est. 20111 employees
Revenue 2025
SEK 0
EBITDA margin
—
+52% vs 2024
Equity ratio
94.2%
Financial strength
Net profit 2025
SEK -26K
+51% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -26K | +52% |
| Net profit | SEK -26K | +51% |
| Total assets | SEK 250K | -22% |
| Equity | SEK 235K | -10% |
| Employees | 1 | — |
Legal name
BolMed AB
Org number
5568395106
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
26 januari 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolagets verksamhet är sjukvård, utbildning och förvaltning av värdepapper och därmed förenlig verksamhet.
Address
Vasavägen 47
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 220 | 27 | 249 | 0 | 0 |
| Staff expenses | — | −2 | −10 | −4 | −0 |
| EBITDA | 181 | 4 | 200 | −55 | −26 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 181 | 4 | 200 | −55 | −26 |
| Net financials | — | −1 | 0 | 2 | 0 |
| Profit before tax | 188 | 4 | 200 | −53 | −26 |
| Tax | −41 | −2 | −44 | — | — |
| Net profit | 147 | 2 | 156 | −53 | −26 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 407 | 288 | 476 | 320 | 250 |
| Equity | 357 | 259 | 415 | 261 | 235 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 50 | 30 | 61 | 58 | 15 |
| Total debt | 50 | 30 | 61 | 58 | 15 |
EBITDA margin
-2630400.0%
This company
15.8%
Market median
-16648201% vs market
20212025
Equity ratio
94.2%
This company
38.2%
Market median
+147% vs market
20212025
Return on equity
-11.1%
This company
18.4%
Market median
-160% vs market
20212025
Net profit margin
-2601500.0%
This company
8.1%
Market median
-32117384% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BolMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Magnus Bolmstrand | Deputy Board Member | 0 companies |
| Björn Magnus Bolmstrand | Board of Directors | 0 companies |